Abiopharma

🔍 Gomide de Faria Mariano (Executive)

Company: VTEX (NYSE: VTEX)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Sold 4,808 shares of Class A Common Shares at $4.0 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 1,067,585.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Shares (Direct)
  Date: 2026-06-26 | Code: H | shares_owned_after: 601,797.00
• Holds 0 shares of Class A Common Shares (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By Class M | shares_owned_after: 14,100.00

Footnotes:

• F1: Represents sales effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on October 11, 2025.
• REMARKS: Due to the Issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the Issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.